Most U.S. hedge funds aren't expecting another big stock market sell-off as more firms curb bets on volatility, according to Nomura.Marketsread more
More tit-for-tat tariffs in the U.S.-China trade war could set the global economy up for a recession, according to Morgan Stanley.Marketsread more
A sell-off in chip stocks intensified following a report that chipmakers are cutting ties with Huawei after the Trump administration's ban.Marketsread more
A series of tweets Monday marked the latest chapter in Trump's decadeslong effort to refute published reports that his previous financial problems have rendered him an...Politicsread more
President Trump stands a chance of creating a new economic world order in his China trade fight, says the chief economic advisor of Allianz.Economyread more
Sens. Mitch McConnell and Tim Kaine plan to introduce a bill Monday that would raise the minimum age to buy tobacco to 21 in hopes of curbing what regulators are calling an...Health and Scienceread more
Ford Motor said Monday that it is laying off about 7,000 salaried workers, about 10% of that global workforce, as part of a restructuring plan designed to save the No. 2...Autosread more
Google announced Google Glass Enterprise Edition 2 on Monday, a new set of smart glasses that's catered toward businesses and costs $999. Google has focused on business use...Technologyread more
Restaurants are thinking outside the box to attract and retain talent. A report from TDn2K, a restaurant analytics firm, finds that employee vacancies are a major concern for...Restaurantsread more
Major producers strongly signaled they will extend output cuts, which have helped to boost oil prices by about $20 a barrel this year.Energyread more
Before the winner would even get a dime, more than $54 million would be withheld for federal taxes. Much more would likely be due at tax time.Personal Financeread more
Check out the companies making headlines midday Monday:
Boeing — Shares of Boeing dropped 4.44% after Bank of America Merrill Lynch cut its rating to neutral from buy after Boeing announced it plans to cut production of the jet on Friday. The bank expects delays with 737 will last six to nine months.
Southwest Airlines — The airline fell 2.46% after Raymond James downgraded it to hold from buy, citing concerns that Boeing jet groundings could last through peak summer travel. Southwest has 34 Max jets which account for roughly 4 percent of the airline's passenger capacity.
General Electric — GE tumbled 5.19% after J.P. Morgan's Stephen Tusa downgraded the stock underweight from neutral and cut his 12-month price target to $5 from $6. "We believe many investors are underestimating the severity of the challenges and underlying risks at GE, while overestimating the value of small positives," wrote Tusa in a note to clients.
Sony — Shares of Sony surged 7.3% and ended the day little changed after Reuters reported that Daniel Loeb's Third Point is building a stake in the company and plans to push for changes. Third Point is reportedly raising an investment vehicle to generate between $500 million and $1 billion to continue buying Sony shares. This is the second time in 6 years that the hedge fund has targeted Sony.
J. Alexander Holdings — The Southern restaurant chain's stock rallied more than 8% after activist investor Ancora Advisors announced an offer to take the company private for $11.75 per share. The offering represented more than a 12% premium to Friday's closing price.
Symantec — Symantec jumped more than 5% after an analyst at Goldman Sachs upgraded the stock to buy from neutral, highlighting an "undemanding" valuation and a "to sustained growth in current billings."
AMC Entertainment — Shares of the movie theater company surged 92u% after B. Riley FBR upgraded them to buy from neutral. The firm cited a strong line-up of films coming out in the spring and summer, which includes Marvel's "Avengers: Endgame."
2U — Shares of the educational technology company dropped about 3.4% after 2U announced it is purchasing Trilogy Education Services for $750 million.
United Therapeutics —United Therapeutics fell around 5.7% after the company announced its clinical study of esuberaprost tablets did not meet its primary endpoint. The biotechnology company is discontinuing product development for the pulmonary arterial hypertension treatment.